Research reveals regional variations in COPD diagnoses across England
In News
Follow this topic
Bookmark
Record learning outcomes
Research by the pharmaceutical company Chiesi has shown regional variations in diagnoses of chronic obstructive pulmonary disease (COPD) across England.
Chiesi’s analysis of Office for National Statistics, Office for Health Improvement and Disparities and NHS COPD diagnosis data per integrated care board area revealed the number of current smokers and ex-smokers aged 55 to 74 who may be at risk of the condition but are not currently recorded on a COPD register.
There was “a more than threefold regional gap in the proportion of people who could benefit from COPD checks” between Lincolnshire with 13.1 per cent and South-East London with 4.1 per cent. It is thought more than two million people have undiagnosed COPD in the UK.
Chiesi, who said Asthma UK are supporting its research, published an England-wide heat map highlighting the estimated number of people who could be at risk but have not been identified and what proportion of the GP-registered population that makes up in each area.
For example, it showed about 249,831 people are at risk of COPD but are not recorded on a register in the North-East and North Cumbria compared with 167,942 people in Sussex. Lincolnshire, Devon, and Cornwall and the Isles of Scilly had the highest proportion of people identified for potential assessment.
The North-East and North Cumbria, Greater Manchester and West Yorkshire produced the largest numbers of people, “reflecting their larger populations”, the study noted.
Chiesi said “wider evidence” showed people from the poorest 10 per cent of households are more than two-and-a-half times more likely to have COPD than people from the most affluent.
People aged 45 to 54 living with COPD in the poorest communities in England are around nine times more likely to be admitted to hospital than those in the least deprived.
Chiesi said the findings of its research “support population health-planning and diagnostic prioritisation” and “identify opportunities for further assessments” but “should not be interpreted as confirmed undiagnosed COPD prevalence”.
Harriet Lewis, senior director, public affairs and communications, Chiesi UK and Ireland, said: “These findings highlight where targeted assessment could help identify more people who may be living with COPD without knowing it.
“By making local evidence accessible, we aim to support healthcare professionals and NHS leaders in planning diagnostic services around their communities’ needs.
“Chiesi will continue to work with our NHS partners to support earlier diagnosis and access to high-quality lung function testing, helping more people receive the right care at the right time.”